Mr. Daniel Southan-Dwyer reports

PANGENOMIC HEALTH ANNOUNCES STOCK OPTION GRANTS

Pangenomic Health Inc.'s board of directors has granted stock options, representing a total of two million common shares, to officers and directors of the company and its subsidiaries. These options were granted at an exercise price of 65 cents, being the closing price on Dec. 4, 2025, will vest in equal quarterly instalments over a one-year period and will expire on Dec. 5, 2028. All options were granted pursuant to the company's stock option plan.

About Pangenomic Health Inc.

Pangenomic Health is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments. The company's initial focus is to support mental health. Registered as a British Columbia benefit company, Pangenomic Health's mission is to promote and improve the health and wellness of people and society by providing a technology platform that identifies plant-based solutions tailored to the health profile of each individual.

We seek Safe Harbor.